A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor
NCT07243340
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioma, Malignant
Interventions
BIOLOGICAL:
Herpes Virus C5252 Injection
Sponsor
ImmVira Pharma Co. Ltd